New sleep drug could help those battling opioid addiction
NCT ID NCT06655883
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether suvorexant, a sleep medication, can help people with opioid use disorder fall asleep and stay asleep. About 300 participants will receive either suvorexant or a placebo. The goal is to see if the drug improves total sleep time and is safe to use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
suvorexant
What this could lead to
If it works, this could provide a safe, effective sleep aid for people with opioid use disorder who struggle with insomnia.
What could go wrong
This is a phase 3 trial, but insomnia treatments often have mixed results. Suvorexant may not work better than placebo, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Adams Clinical Dallas ( Site 2007)
RECRUITINGDeSoto, Texas, 75115, United States
Contact Phone: •••-•••-••••
-
Butler Hospital ( Site 1002)
RECRUITINGProvidence, Rhode Island, 02906, United States
Contact Phone: •••-•••-••••
-
CenExel iResearch, LLC ( Site 2010)
RECRUITINGSavannah, Georgia, 31405, United States
Contact Phone: •••-•••-••••
-
Hassman Research Institute Marlton Site ( Site 2005)
RECRUITINGMarlton, New Jersey, 08053, United States
Contact Phone: •••-•••-••••
-
Johns Hopkins University ( Site 1001)
RECRUITINGBaltimore, Maryland, 21224, United States
Contact Phone: •••-•••-••••
-
Medical University of South Carolina ( Site 1005)
RECRUITINGCharleston, South Carolina, 29403, United States
Contact Phone: •••-•••-••••
-
Memorial Hermann Village ( Site 2001)
RECRUITINGHouston, Texas, 77043, United States
Contact Phone: •••-•••-••••
-
Penn Medicine University of Pennsylvania Health System- Center for Studies of Addiction ( Site 1006)
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Phone: •••-•••-••••
-
The Rivus Wellness & Research Institute ( Site 2014)
RECRUITINGOklahoma City, Oklahoma, 73112, United States
Contact Phone: •••-•••-••••
-
VCU Institute for Drug and Alcohol Studies ( Site 1004)
RECRUITINGRichmond, Virginia, 23219, United States
Contact Phone: •••-•••-••••
-
Yale University School of Medicine ( Site 1003)
RECRUITINGNew Haven, Connecticut, 06520, United States
Contact Phone: •••-•••-••••